News | April 07, 2008

CAD Risk Less, Endothelial Function Improved in Cleaner Environment

April 8, 2008 - A study using Itamar Medical's Endo-PAT2000, an FDA-cleared device used to assess endothelial function, found that when indoor air particles are reduced in a controlled study environment, endothelial function, an indicator of cardiovascular health, significantly improves.

Itamar Medical's Endo-PAT2000 was used for evaluating the effect of high-efficiency particulate air (HEPA) filters on endothelial function in healthy elderly patients residing close to major roads. Vaclavik et al. found that air filtration significantly improved endothelial function in the study subjects (Vaclavik et al. Indoor Particles Affect Vascular Function in the Aged. American Journal of Respiratory and Critical Care Medicine 2008; Vol 177. pp. 419-425). Endothelial function is an important indicator of vascular health, so much so that endothelial dysfunction has been described as the "ultimate risk of risk factors" (Bonetti et al., Endothelial Dysfunction: A Marker of Atherosclerotic Risk, ATVB, 2003;23;168-175).

Both short-term and long-term exposure to ambient levels of particulate are associated with increased fatalities related to respiratory and cardiovascular disease. Researchers in the study believe endothelial dysfunction, which is a strong predictor of adverse cardiovascular conditions, may be the source of this increase in respiratory and cardiovascular diseases.

For more information: www.itamar-medical.com


Related Content

News | Stents Drug Eluting

October 31, 2023 — SMT (Sahajanand Medical Technologies), a leading medical device company in India, focused on ...

Home October 31, 2023
Home
News | Stents Drug Eluting

October 10, 2023 — Elixir Medical, a developer of innovative cardiovascular technologies, announced it will present ...

Home October 10, 2023
Home
News | Stents Drug Eluting

July 13, 2023 — Elixir Medical, a developer of breakthrough cardiovascular technologies, announced enrollment completion ...

Home July 13, 2023
Home
News | Stents Drug Eluting

July 12, 2023 — In a late breaking trial session during EuroPCR 2023 in Paris, on behalf of the HOST-IDEA study ...

Home July 12, 2023
Home
News | Stents Drug Eluting

May 25, 2023 — First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic ...

Home May 25, 2023
Home
News | Stents Drug Eluting

January 2, 2023 — The U.S. Food and Drug Administration (FDA) has approved the BioFreedom Drug Coated Coronary Stent ...

Home January 02, 2023
Home
News | Stents Drug Eluting

December 23, 2022 — According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be ...

Home December 23, 2022
Home
News | Stents Drug Eluting

June 2, 2022 — Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, announced print ...

Home June 02, 2022
Home
News | Stents Drug Eluting

February 16, 2022 – Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, has announced ...

Home February 16, 2022
Home
News | Stents Drug Eluting

January 26, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's Synergy Megatron Drug ...

Home January 26, 2021
Home
Subscribe Now